Company Encyclopedia
View More
name
XUNFEIHEALTH
02506.HK
Xunfei Healthcare Technology Co., Ltd. provides healthcare AI solutions in the People’s Republic of China. The company offers PHC services, including a general practice clinical decision support system (CDSS) and chronic disease management, which provides screening, risk categorization, and grading, follow-ups, personalized health education, and lifestyle interventions. It also offers smart hospital solutions, including smart service, smart healthcare, smart medical treatment combination, as well as the iFlytek Xiaoyi APP, an AI health assistant.
33.19 B
02506.HKMarket value -Rank by Market Cap -/-

Financial Score

17/12/2025 Update
C
Health Care TechnologyIndustry
Industry Ranking2/7
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-12.05%D
    • Profit Margin-9.59%D
    • Gross Margin51.54%B
  • Growth ScoreA
    • Revenue YoY36.18%A
    • Net Profit YoY56.41%B
    • Total Assets YoY86.17%A
    • Net Assets YoY110.87%A
  • Cash ScoreC
    • Cash Flow Margin-1042.84%E
    • OCF YoY36.18%A
  • Operating ScoreC
    • Turnover0.45C
  • Debt ScoreD
    • Gearing Ratio60.36%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Top 10 HK Stock Gainers (12.8)

    LEMO SERVICES(02539) rose 47.86%, with a trading turnover 35.7 Million HKD, and a year-to-date rose 112%. TIANYU SEMI(02658) rose 27.65%, with a trading turnover 126.8 Million HKD, and a year-to-date fell 10.9%. TANWAN(09890) rose 11.63%, with a trading turnover 134.3 Million HKD, and a year-to-date rose 98.6%.

    Top Gainers & Losers·
    HK
    02539
    -0.98%
    HK
    02658
    -0.41%
    HK
    09890
    +3.98%
    Top Gainers & Losers·
    HK
    02539
    -0.98%
    HK
    02658
    -0.41%
    HK
    09890
    +3.98%

    Hong Kong stocks intraday | The three major indices fluctuated narrowly, POP MART fell over 8%, popular pharmaceutical stock Innovent Biologics plummeted, and multiple individual stocks rose over 10%

    So far, the three major indices of the Hong Kong stock market have shown an overall volatile pattern, with the Hang Seng Index declining, while the technology sector has performed relatively steadily. There is a clear differentiation between retail and hardware, and the biotechnology sector is under significant pressure from capital outflows. The market is characterized by a strong wait-and-see atmosphere, with some individual stocks experiencing significant fluctuations driven by major events

    Market Heartbeat·
    HK
    02506
    -1.95%
    Market Heartbeat·
    HK
    02506
    -1.95%

    CITIC International has lowered the target price and revenue growth forecast for XUNFEIHEALTH, with fluctuations observed in the B-end business

    CMB International lowered the target price for XUNFEIHEALTH to RMB 143.59 and revised the compound annual growth rate forecast for revenue from 2024 to 2026 down to 27.9%. The report noted that revenue from the G-end business grew by 87% year-on-year, while revenue from the B-end business declined by 10%. Overall revenue increased by 30% year-on-year, with improved operating efficiency, but the medical artificial intelligence industry still faces challenges from demand fluctuations. Nevertheless, CMB International maintains a "Buy" rating for the company

    AASTOCKS·
    HK
    02506
    -1.95%
    AASTOCKS·
    HK
    02506
    -1.95%

    XUNFEIHEALTH released its interim results, with a gross profit of 154 million yuan, an increase of 26.96% year-on-year

    XUNFEIHEALTH released its interim results for the period ending June 30, 2025, with operating revenue of 299 million yuan, a year-on-year increase of 30.26%; gross profit of 154 million yuan, a year-on-year increase of 26.96%. The revenue growth is mainly attributed to significant improvements in grassroots solutions, patient management services, and regional solutions. The company also launched the Xunfei Spark Medical Model X1 based on deep reasoning technology and collaborated with Huawei to introduce a fully localized medical integrated machine, enhancing the performance and application effects of medical intelligent agents

    Zhitong·
    HK
    02506
    -1.95%
    Zhitong·
    HK
    02506
    -1.95%

    XUNFEIHEALTH has been awarded a Wind ESG rating of A: A benchmark for sustainable development in the AI medical field

    XUNFEIHEALTH has been awarded an A rating in the latest ESG assessment by Wind, with a total score of 7.55, exceeding the industry average of 6.08, ranking 24th among 245 information technology service companies. The company has excelled in corporate governance, social responsibility, and environmental management, particularly in employee rights, information security, and diversity. XUNFEIHEALTH will also move into Xunfei Town, which focuses on green and energy-saving principles, in 2024 to further promote sustainable development

    Zhitong·
    HK
    02506
    -1.95%
    Zhitong·
    HK
    02506
    -1.95%
    © 2025 Longbridge｜Disclaimer